Pain and quality of life (QoL) in patients with locally recurrent rectal cancer (LRRC)
Masafumi Ikeda(National Cancer Center Hospital East), Morito Monden(Unknown), Ichiro Takemasa(Osaka International University), Hideki Yamamoto, Tsunetake Hata, Masayoshi Yasui(Osaka International Cancer Institute), M Sekimoto(Osaka National Hospital), M. Ikenaga(Osaka National Hospital), Tatsushi Shingai(Kinki Central Hospital), Yujiro Fujie(The University of Osaka), Masayuki Ohue(Hyogo Medical University)
Cited by 0
Related Papers
Durvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer
|NEJM Evidence|2022|1.1k
Randomized Phase III Study of Gemcitabine Plus S-1, S-1 Alone, or Gemcitabine Alone in Patients With Locally Advanced and Metastatic Pancreatic Cancer in Japan and Taiwan: GEST Study
|Journal of Clinical Oncology|2013|632